Last reviewed · How we verify
NCT05740436: POSTSCRIPTUM
Protocol of Geriatric Rehabilitation in Patients of 60 and Older Who Live in Moscow Boarding Houses or Nursing Homes
trial testing Geriatric rehabilitation program based on CGA in Frail Elderly Syndrome in 420 participants. Completed in 31 August 2024.
31 August 2023
Quick facts
| Lead sponsor | Pirogov Russian National Research Medical University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 420 |
| Start date | 21 August 2021 |
| Primary completion | 31 August 2023 |
| Estimated completion | 31 August 2024 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- Geriatric rehabilitation program based on CGA
Conditions studied
- Frail Elderly Syndrome — all drugs for Frail Elderly Syndrome →
Sponsor
Pirogov Russian National Research Medical University
Who can join
60 and older, any sex, with Frail Elderly Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
After screening complex geriatric assessment (CGA) the participants will undergo geriatric rehabilitation programs. After termination of 21-day program, CGA will be repeated and subjects will get a program of long-term rehabilitation. A phone call in six months and a face-to-face visit in 12 months will be scheduled to follow-up and to evaluate the progress in rehabilitation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05740436
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Frail Elderly Syndrome
Currently open trials in the same condition.
- NCT06857981 — Patient's Database: Prepare for Your Surgery Program · recruiting
- NCT06469437 — The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM · NA · recruiting
- NCT06444321 — INTEgRated Health CARE for Patients With Frailty and Heart Failure · NA · recruiting
- NCT05993754 — Non-pharmacological Prevention of POD in Frailty Elderly Undergoing Elective Surgery Applied by Nursing Teams · NA · recruiting
- NCT06496022 — Comparative Analysis of Risk Factors and Prediction of Frailty Syndrome · active not recruiting
Other Pirogov Russian National Research Medical University trials
Trials by the same sponsor.
- NCT07449728 — The Influence of Laser Crossectomy With Different Wavelengths on Varicose Vein Progression · NA · recruiting
- NCT07363603 — Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. · Phase 1, PHASE2 · recruiting
- NCT07083986 — Carotid Endarterectomy Versus Stenting in Patients With Acute Stage of Ischemic Stroke. · NA · enrolling by invitation
- NCT06766968 — Prolonged Compression Following Foam Sclerotherapy · NA · active not recruiting
- NCT06753786 — Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05740436 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pirogov Russian National Research Medical University
- Last refreshed: 13 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05740436.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing